{"company":{"id":1828054,"name":"Jazz Pharmaceuticals Iberia S.L.","domain":"jazzpharma.com","url":"https://alion.io/company/jazzpharma"},"section":"financials","answer":"Jazz Pharmaceuticals Iberia S.L. filed revenue of $4.3B for 2025.","figures":[{"label":"Revenue, 2025","value":"$4.3B"},{"label":"Net income, 2025","value":"−$356.1M"}],"blocks":[{"key":"results","title":"Results by year","source":"SEC","rows":15}],"results":[{"year":"2025","revenue":"$4.3B","net_income":"−$356.1M","assets":"$11.7B","tax_paid":"$121.8M","tax_expense":"−$272.4M","buybacks":"$125M","capex":"$58.8M","sbc":"$291.1M","rnd":"$782.7M","operating_income":"−$430.2M","cash":"$1.4B","debt":"$4.3B","acquisitions":"–"},{"year":"2024","revenue":"$4.1B","net_income":"$560.1M","assets":"$12B","tax_paid":"$114.9M","tax_expense":"−$91.4M","buybacks":"$311.4M","capex":"$38.1M","sbc":"$248M","rnd":"$884M","operating_income":"$716.6M","cash":"$2.4B","debt":"$6.1B","acquisitions":"–"},{"year":"2023","revenue":"$3.8B","net_income":"$414.8M","assets":"$11.4B","tax_paid":"$177.9M","tax_expense":"−$119.9M","buybacks":"$269.8M","capex":"$24M","sbc":"$226.8M","rnd":"$849.7M","operating_income":"$578.6M","cash":"$1.5B","debt":"$5.1B","acquisitions":"$0"},{"year":"2022","revenue":"$3.7B","net_income":"−$224.1M","assets":"$10.8B","tax_paid":"$94.7M","tax_expense":"−$158.6M","buybacks":"$54k","capex":"$29M","sbc":"$222M","rnd":"$590.5M","operating_income":"−$65.5M","cash":"$881.5M","debt":"$5.7B","acquisitions":"$0"},{"year":"2021","revenue":"$3.1B","net_income":"−$329.7M","assets":"$12.3B","tax_paid":"$271.2M","tax_expense":"$216.1M","buybacks":"$0","capex":"$27.6M","sbc":"$189M","rnd":"$505.7M","operating_income":"$170.3M","cash":"$591.4M","debt":"$6B","acquisitions":"$6.2B"},{"year":"2020","revenue":"$2.4B","net_income":"$238.6M","assets":"$6.5B","tax_paid":"$226.8M","tax_expense":"$33.5M","buybacks":"$146.5M","capex":"$15M","sbc":"$121M","rnd":"$335.4M","operating_income":"$378.1M","cash":"$1.1B","debt":"$1.8B","acquisitions":"$0"},{"year":"2019","revenue":"$2.2B","net_income":"$523.4M","assets":"$5.5B","tax_paid":"$183.6M","tax_expense":"−$73.2M","buybacks":"$301.5M","capex":"$40.1M","sbc":"$110.6M","rnd":"$299.7M","operating_income":"$532.4M","cash":"$637.3M","debt":"$1.6B","acquisitions":"$0"},{"year":"2018","revenue":"$1.9B","net_income":"$447.1M","assets":"$5.2B","tax_paid":"$164.2M","tax_expense":"$80.2M","buybacks":"$523.7M","capex":"$20.4M","sbc":"$102.4M","rnd":"$226.6M","operating_income":"$614.8M","cash":"$309.6M","debt":"$1.6B","acquisitions":"$0"},{"year":"2017","revenue":"$1.6B","net_income":"$487.8M","assets":"$5.1B","tax_paid":"$174.1M","tax_expense":"−$47.7M","buybacks":"$98.8M","capex":"$29M","sbc":"$106.9M","rnd":"$198.4M","operating_income":"$528.8M","cash":"$386M","debt":"$1.5B","acquisitions":"$0"},{"year":"2016","revenue":"$1.5B","net_income":"$396.8M","assets":"$4.8B","tax_paid":"$160.3M","tax_expense":"$135.2M","buybacks":"$278.3M","capex":"$9.7M","sbc":"$98.8M","rnd":"$162.3M","operating_income":"$591.7M","cash":"$366M","debt":"$2B","acquisitions":"$1.5B"},{"year":"2015","revenue":"$1.3B","net_income":"$329.5M","assets":"$3.3B","tax_paid":"$145.6M","tax_expense":"$106.4M","buybacks":"$61.6M","capex":"$36M","sbc":"$91.6M","rnd":"$135.3M","operating_income":"$508.2M","cash":"$988.8M","debt":"$1.2B","acquisitions":"$0"},{"year":"2014","revenue":"$1.2B","net_income":"$58.4M","assets":"$3.3B","tax_paid":"$108.2M","tax_expense":"$94.2M","buybacks":"$42.2M","capex":"$36.3M","sbc":"$69.6M","rnd":"$85.2M","operating_income":"$195.6M","cash":"$684M","debt":"$1.3B","acquisitions":"$828.7M"},{"year":"2013","revenue":"$872.4M","net_income":"$216.3M","assets":"$2.2B","tax_paid":"$137.6M","tax_expense":"$91.6M","buybacks":"$136.5M","capex":"$10M","sbc":"$44.6M","rnd":"$41.6M","operating_income":"$340.3M","cash":"$636.5M","debt":"$544.4M","acquisitions":"$0"},{"year":"2012","revenue":"$586M","net_income":"$288.6M","assets":"$2B","tax_paid":"$9.1M","tax_expense":"−$83.8M","buybacks":"$0","capex":"$6M","sbc":"$23M","rnd":"$20.5M","operating_income":"$197.8M","cash":"$387.2M","debt":"$427.1M","acquisitions":"$542.5M"},{"year":"2011","revenue":"$272.3M","net_income":"$125M","assets":"$253.6M","tax_paid":"$0","tax_expense":"$0","buybacks":"$0","capex":"$1.3M","sbc":"$20.7M","rnd":"$14.1M","operating_income":"$127.8M","cash":"$82.1M","debt":"$0","acquisitions":"$0"}],"as_of":"2026-11-19","cite":"Jazz Pharmaceuticals Iberia S.L., Financials. Alion, Nov 19, 2026. https://alion.io/company/jazzpharma/financials","html_url":"https://alion.io/company/jazzpharma/financials","json_url":"https://alion.io/company/jazzpharma/financials.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-19T14:23:00Z"}}